The Nobel Prize in Physiology or Medicine is announced on the first Monday in October every year.
The Nobel Assembly at Karolinska Institutet has decided to award the 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation.
Individuals with an inherited form of skin cancer often have a poor prognosis. The type of immunotherapy that was awarded this year’s Nobel Prize in Physiology or Medicine is, however, particularly effective in this patient group, research from Karolinska Institutet in Sweden shows.
This year’s Nobel Prize in Physiology or Medicine recognizes the discovery that it is possible to treat cancer by inhibiting the brakes on the immune system. Many factors contribute to rapid developments in this field—in particular, current research at Karolinska Institutet.
The 2017 Nobel Prize in Physiology or Medicine is awarded jointly to Jeffrey C. Hall, Michael Rosbash and Michael W. Young for their discoveries of molecular mechanisms controlling the circadian rhythm.
Our body clock controls us more than we realise. If this 2017’s Nobel-Prize-winning discovery has a wider breakthrough, it can change everything from when the school day will start to what medicines we take and when.
It was a packed Aula Medica that listened to Jeffrey C. Hall, Michael Rosbash and Michael W. Young as they delivered their Nobel lectures.